Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Combined Immunodeficiency”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00076791
What this trial is testing

Safety of Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine/TDF in HIV Infected Pregnant Women and Their Infants

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 66
Early research (Phase 1)UnknownNCT03588715
What this trial is testing

Peg-Interferon Alpha 2b Combined With Two Intravenous Broadly HIV-1 Neutralizing Antibodies 3BNC117 and 10-1074 (BEAT-2)

Who this might be right for
HIVHIV/AIDSHIV-1 Infection
Luis Montaner 15
Large-scale testing (Phase 3)Study completedNCT00561925
What this trial is testing

VERxVE Study on Efficacy and Safety of Nevirapine XR in Comparison to Nevirapine IR With Truvada in Naive HIV+ Patients

Who this might be right for
HIV Infections
Boehringer Ingelheim 1,068
Testing effectiveness (Phase 2)Study completedNCT04930744
What this trial is testing

Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)

Who this might be right for
TuberculosisPulmonary TuberculosisHIV Coinfection
University of Massachusetts, Worcester 112
Testing effectiveness (Phase 2)Study completedNCT05330143
What this trial is testing

Study to Evaluate Safety, Tolerance and Efficacy of ASC22 Combined With ART in Subjects With HIV

Who this might be right for
HIV-1-infectionHIV InfectionsPD-L1 Gene Mutation
Ascletis Pharmaceuticals Co., Ltd. 19
Not applicableUnknownNCT05300334
What this trial is testing

Investigation of ADA Enzyme Deficiency

Who this might be right for
Adenosine Deaminase Deficiency
TRPHARM 800
Testing effectiveness (Phase 2)Study completedNCT00002225
What this trial is testing

Efavirenz in Combination With Stavudine and Didanosine

Who this might be right for
HIV Infections
Dupont Merck 60
Testing effectiveness (Phase 2)Study completedNCT00002452
What this trial is testing

A Study on the Safety and Effectiveness of L-756423 Plus Indinavir in HIV-Positive Patients Who Have Previously Taken Indinavir

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 30
Not applicableNot Yet RecruitingNCT05745168
What this trial is testing

Pilot Implementation of HIV Self-testing Delivery in Private Pharmacies Combined to a Respondent Driven Sampling Method to Improve HIV Testing for MSM and TGW in Phnom Penh - ANRS 0100s

Who this might be right for
HIV Infections
ANRS, Emerging Infectious Diseases 1,500
Early research (Phase 1)Study completedNCT00002321
What this trial is testing

A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Chiron Corporation
Not applicableStudy completedNCT00000693
What this trial is testing

Suppression of Cytomegalovirus Retinitis Utilizing High Dose Intravenous Acyclovir and Oral Zidovudine in Patients With AIDS

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 25
Early research (Phase 1)WithdrawnNCT00068991
What this trial is testing

HIV Educational Programs for Villagers of Funan County or Yingzhou District, Anhui Province, China

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Large-scale testing (Phase 3)Study completedNCT00002374
What this trial is testing

Saquinavir Soft Gelatin Capsules Combined With Other Anti-HIV Drugs in HIV-1 Infected Patients

Who this might be right for
HIV Infections
Hoffmann-La Roche 120
Not applicableStudy completedNCT02191293
What this trial is testing

Long-term Study in Patients Under Anti-retroviral Combination Therapy Switching to Viramune®

Who this might be right for
HIV Infections
Boehringer Ingelheim 228
Testing effectiveness (Phase 2)Study completedNCT03819114
What this trial is testing

Pharmacokinetic Study to Evaluate Double-Dose Levonorgestrel Emergency Contraception in Combination With Efavirenz-Based Antiretroviral Therapy or Rifampicin-Containing Anti-Tuberculosis Therapy

Who this might be right for
HIV InfectionsTuberculosis
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 122
Testing effectiveness (Phase 2)UnknownNCT03315078
What this trial is testing

Lentiviral Gene Transfer for Treatment of Children Older Than 2 Years of Age With X-Linked Severe Combined Immunodeficiency

Who this might be right for
X-Linked Combined Immunodeficiency Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 13
Large-scale testing (Phase 3)Study completedNCT02131233
What this trial is testing

Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)

Who this might be right for
HIV Infection
Merck Sharp & Dohme LLC 802
Not applicableStudy completedNCT00002155
What this trial is testing

A Six-Month Safety and Antiviral Study in HIV-1 Seropositive, AZT-Experienced Patients With CD4 Counts Less Than or Equal to 50 Cells/mm3 to Evaluate MK-639 Alone Versus Zidovudine (AZT) and 3TC Versus the Combination of MK-639 With AZT/3TC

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 600
Not applicableUnknownNCT01042652
What this trial is testing

A Trial to Compare Raltegravir Versus Nevirapine as Anchor Drug for HIV+ Chinese IDUs on Methadone Maintenance

Who this might be right for
HIVHIV Infections
Centers for Disease Control and Prevention, China 60
Early research (Phase 1)Study completedNCT00001026
What this trial is testing

A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines in Vaccinia-Naive Individuals

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 56
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation